🚀 VC round data is live in beta, check it out!
EBM Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for EBM Technologies and similar public comparables like CareView Communications, Diagnos, NanoRepro, CurveBeam AI and more.
EBM Technologies Overview
About EBM Technologies
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
Founded
1988
HQ
Employees
116
Website
Financials (FY)
EV
$19M
EBM Technologies Financials
EBM Technologies reported last fiscal year revenue of $8M and EBITDA of $910K.
In the same fiscal year, EBM Technologies generated $6M in gross profit, $910K in EBITDA, and $248K in net income.
EBM Technologies P&L
In the most recent fiscal year, EBM Technologies reported revenue of $8M and EBITDA of $910K.
EBM Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $8M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 69% | XXX | XXX | XXX |
| EBITDA | — | XXX | $910K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 4% | XXX | XXX | XXX |
| Net Profit | — | XXX | $248K | XXX | XXX | XXX |
| Net Margin | — | XXX | 3% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
EBM Technologies Stock Performance
EBM Technologies has current market cap of $21M, and enterprise value of $19M.
Market Cap Evolution
EBM Technologies' stock price is $0.66.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $21M | 0.5% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEBM Technologies Valuation Multiples
EBM Technologies trades at 2.4x EV/Revenue multiple, and 21.0x EV/EBITDA.
EBM Technologies Financial Valuation Multiples
As of April 20, 2026, EBM Technologies has market cap of $21M and EV of $19M.
Equity research analysts estimate EBM Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
EBM Technologies has a P/E ratio of 85.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $21M | XXX | $21M | XXX | XXX | XXX |
| EV (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 21.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 61.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.4x | XXX | XXX | XXX |
| P/E | — | XXX | 85.4x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (8.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified EBM Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
EBM Technologies Margins & Growth Rates
EBM Technologies' revenue in the last fiscal year declined by (10%).
EBM Technologies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
EBM Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 22% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 21% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 65% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
EBM Technologies Public Comps
See public comps and valuation multiples for other Healthcare Software and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| EBM Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| CareView Communications | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnos | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoRepro | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Healixa | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
EBM Technologies M&A Activity
EBM Technologies acquired XXX companies to date.
Last acquisition by EBM Technologies was on XXXXXXXX, XXXXX. EBM Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by EBM Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEBM Technologies Investment Activity
EBM Technologies invested in XXX companies to date.
EBM Technologies made its latest investment on XXXXXXXX, XXXXX. EBM Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by EBM Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout EBM Technologies
| When was EBM Technologies founded? | EBM Technologies was founded in 1988. |
| Where is EBM Technologies headquartered? | EBM Technologies is headquartered in Taiwan. |
| How many employees does EBM Technologies have? | As of today, EBM Technologies has over 116 employees. |
| Is EBM Technologies publicly listed? | Yes, EBM Technologies is a public company listed on Taipei Exchange. |
| What is the stock symbol of EBM Technologies? | EBM Technologies trades under 8409 ticker. |
| When did EBM Technologies go public? | EBM Technologies went public in 2012. |
| Who are competitors of EBM Technologies? | EBM Technologies main competitors are CareView Communications, Diagnos, NanoRepro, CurveBeam AI. |
| What is the current market cap of EBM Technologies? | EBM Technologies' current market cap is $21M. |
| What is the current revenue of EBM Technologies? | EBM Technologies' last fiscal year revenue is $8M. |
| What is the current EV/Revenue multiple of EBM Technologies? | Current revenue multiple of EBM Technologies is 2.4x. |
| Is EBM Technologies profitable? | No, EBM Technologies is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.